Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).

Nevro Corp is a medical device company. Its key product is the ... It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a ...

Redwood City, California-based Nevro sells spinal cord stimulation devices for back pain and painful diabetic neuropathy, a complication of diabetes associated with pain or tingling in the arms ...

(RTTNews) - Globus Medical (GMED), a musculoskeletal solutions company, Thursday agreed to acquire Nevro Corp. (NVRO), a medical device company, in an all-cash transaction. Under the terms of the ...

Nevro Corp. engages in the development of medical devices. The firm focuses on providing products that improve the quality of life of patients suffering from debilitating chronic pain. It develops ...

United Kingdom, London, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Introspective Market Research reports that the Active Implantable Medical Devices Market around the world was USD 25.48 billion in 2023 ...

Jan. 13, 2025 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today ...

NEVRO’s HF10 therapy runs at 10 kHz and maintains stable outcomes for chronic trunk pain over more than 2 years of continuous monitoring. Japan’s Ministry of Health granted approval in early 2024 to a ...